| Pharmaceutical Information |
| Drug Name |
Nepafenac |
| Drug ID |
BADD_D01555 |
| Description |
Nepafenac is a non-steroidal anti-inflammatory prodrug (NSAID) usually sold as a prescription eye drop. It is used to treat pain and inflammation associated with cataract surgery. |
| Indications and Usage |
For the treatment of pain and inflammation associated with cataract surgery. |
| Marketing Status |
Prescription |
| ATC Code |
S01BC10 |
| DrugBank ID |
DB06802
|
| KEGG ID |
D05143
|
| MeSH ID |
C414203
|
| PubChem ID |
151075
|
| TTD Drug ID |
D02IHW
|
| NDC Product Code |
69988-0005; 0078-0743; 53296-0099; 64181-0019; 42571-353; 73309-311; 0065-0002; 58567-104 |
| Synonyms |
nepafenac | 2-amino-3-benzoylbenzeneacetamide | Nevanac |
|
| Chemical Information |
| Molecular Formula |
C15H14N2O2 |
| CAS Registry Number |
78281-72-8 |
| SMILES |
C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
